Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Cardiology

  • Article

    Ultrasound JVP measurement accurately predicts right atrial pressure

    April 1, 2022

    Dr. Cunningham Clinical question: Does measurement of ultrasound jugular venous pressure (JVP) height by ultrasound (uJVP) in the semi-upright position accurately predict right atrial pressure...

  • Article

    Improved cardiovascular outcomes with CABG compared to FFR-guided PCI in patients with three-vessel CAD

    April 1, 2022

    Dr. Cunningham Clinical question: How does fractional flow reserve (FFR)-guided percutaneous intervention (PCI) with second-generation drug-eluting stents compare with coronary artery bypass...

  • Article

    Effect of vasopressin and methylprednisolone versus placebo on return of spontaneous circulation in patients with in-hospital cardiac arrest

    January 7, 2022

      Dr. Miller Clinical question: Does the administration of vasopressin and methylprednisolone during in-hospital cardiac arrest improve the likelihood of return of spontaneous circulation...

  • Article

    No difference in outcomes comparing the treatment of cardiogenic shock with dobutamine versus milrinone

    January 7, 2022

    Dr. Winget Clinical question: Is there a benefit to selecting milrinone over dobutamine for inotropic support in patients with cardiogenic shock? Background: Inotropes, particularly milrinone...

  • News

    D-dimer thresholds rule out PE in meta-analysis

    December 14, 2021

    Data from a large review support use of D-dimer levels to diagnose PE without imaging.

  • 1
    News

    Oral step-down therapy for infective endocarditis

    December 13, 2021

    What is oral step-down therapy’s relative clinical effectiveness, compared with prolonged IV antibiotics for infective endocarditis (IE)?

  • 1
    News

    New data on rare myocarditis after COVID-19 vaccination

    December 8, 2021

    Most adolescents and young adults recover quickly from the rare complication of myocarditis following mRNA COVID-19 vaccination, a new study shows.

  • 1
    News

    Apixaban outmatches rivaroxaban for VTE in study

    December 6, 2021

    These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.

  • 1
    News

    Care via video teleconferencing can be as effective as in-person for some conditions

    December 6, 2021

    Video teleconferencing works best for monitoring patients with chronic conditions, according to the author of a new paper.

  • 1
    News

    No serious CV risks for elderly after Pfizer COVID-19 vaccine

    December 2, 2021

    A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.

1 2 3 … 72Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Style Guide for Authors
  • Subscribe
  • Advertise
  • Copyright © 2000-2022 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions